Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY: ABT )

116.40 -0.43 (-0.37%)
Official Closing Price Updated: 7:00 PM EDT, Sep 13, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Abbott Laboratories

< Previous 1 2
...
20 21 22 23 24 25 26 27 28
...
33 34 Next >
$1000 Invested In Abbott Laboratories 10 Years Ago Would Be Worth This Much Today
Abbott Laboratories (NYSE:ABT) has outperformed the market over the past 10 years by 2.16% on an annualized basis producing an average annual return of 13.1%. Currently, Abbott Laboratories has a... 
Via Benzinga
Abbott Reopens Its Michigan Plant Closed Due To Floods: Report
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Will This Dry Eye Rapid Test Prove To Be A Rapid Success?
During the last few years of the COVID-19 pandemic, the term “rapid test” conjures images of overlong cotton swabs reaching heretofore untouched corners of nasal cavities. In reality, rapid tests aid... 
Via Benzinga
Senate Finance Committee Probe Reveals How AbbVie Exploits Offshore Subsidiaries To Avoid Tax Bills
Provisions in the 2017 Republican tax law allow AbbVie Inc (NYSE: ABBV) to generate most of its sales in the U.S. while reporting virtually no income in the U.S. for tax purposes. 
Via Benzinga
Abbott Restarts Baby Formula Plant
Abbott shut-down its Sturgis, MI, plant in February as the Food and Drug Administration investigated the deaths of two infants who succumbed to bacterial infections. 
Via Talk Markets
Best Stocks for 2022: AbbVie Is a Recession-Resistant Dividend King
ABBV stock is one of the best choices you can make for 2022. Even though the company is losing its Humira patent soon, it isn't slowing down. 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For July 6, 2022
Upgrades 
Via Benzinga
Could This Company's Gastrointestinal Drug Be A Powerful Pill For People And Animals With Chronic, Debilitating Diarrhea?
San Francisco-based Jaguar Health, Inc. (NASDAQ: JAGX), a commercial-stage pharmaceuticals company, says it is focused on developing novel, plant-based, non-opioid and sustainably derived prescription... 
Via Benzinga
Amazon.com To $180? Here's The Biggest Price Target Changes For Friday
Piper Sandler cut Accenture plc (NYSE: ACN) price target from $368 to $305. Accenture shares gained 4.2% to trade at $297.69 on Friday. 
Via Benzinga
What 6 Analyst Ratings Have To Say About Abbott Laboratories
Abbott Laboratories (NYSE:ABT) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Here's How Much $1000 Invested In Abbott Laboratories 5 Years Ago Would Be Worth Today
Abbott Laboratories (NYSE:ABT) has outperformed the market over the past 5 years by 7.3% on an annualized basis producing an average annual return of 17.14%. Currently, Abbott Laboratories has a market... 
Via Benzinga
Benzinga Before The Bell: Tesla's Cybertruck Update, Twitter's New Feature, Netflix's Ad-Tier And Other Top Financial Stories Thursday, June 23
CNBC Pilot Shortage Pushes American Airlines To Quit Services In 4 Cities 
Via Benzinga
FDA Probes Another Infant Death Given Abbott Formula, Less Than Month After Troubled Plant Reopens
Problems for Abbott Laboratories' (NYSE: ABT) Sturgis plant in Michigan for baby formula powder refuse to subside. The FDA was recently notified of another infant's death who was given formula made at... 
Via Benzinga
What It Means For US Stocks To Be In A Bear Market
Wall Street has officially fallen into a bear market as investor sentiment is hammered by soaring inflation, rising interest rates and worries about a looming recession in the... 
Via Benzinga
Benzinga Before The Bell: Tesla Raises Prices, Revlon Goes Bankrupt And Other Top Financial Stories Thursday, June 16
Wall Street Journal Moderna Plans COVID-19 Vaccine Trial For Infants 
Via Benzinga
More Trouble For Baby Formula Production As Thunderstorms, Flood, Hit Abbott's Troubled Michigan Plant
Via Benzinga
3 Dividend Stocks to Buy Now for 20 Years of Income Growth
Investors looking for passive income from holding stocks should consider these dividend stocks that offer strong payouts. 
Via InvestorPlace
Relief May Soon Be On The Way For Diabetes Sufferers Weary Of Constant Pin Pricks, According To This Company
Last year was the 100th anniversary of the discovery of insulin, which was instrumental in improving people's lives around the world. 
Via Benzinga
7 Undervalued Penny Stocks to Buy for Massive Gains
These seven undervalued penny stocks each have the potential to pay off for investors down later down the road. 
Via InvestorPlace
7 Monkeypox Stocks That May Take Off in Q2
SIGA Technologies (SIGA) may lead on the list of Monkeypox stocks that could soar, but Bavarian Nordic seems to be leading the sales race. 
Via InvestorPlace
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $3,900 Today
Abbott Laboratories (NYSE:ABT) has outperformed the market over the past 10 years by 2.54% on an annualized basis producing an average annual return of 14.5%. Currently, Abbott Laboratories has a... 
Via Benzinga
Analyzing Abbott Laboratories's Short Interest
Abbott Laboratories's (NYSE:ABT) short percent of float has risen 5.48% since its last report. The company recently reported that it has 13.46 million shares sold short, which is... 
Via Benzinga
5 Analysts Have This to Say About Abbott Laboratories
Over the past 3 months, 5 analysts have published their opinion on Abbott Laboratories (NYSE:ABT) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
SOBRsafe CEO Reports Boosting Holdings In Company
Photo by Vinicius "amnx" Amano on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. Dave Gandini is... 
Via Benzinga
Abbott Stock Looks To Emerge From Bear Market Stronger
Abbott stock also has a 92 Composite Rating, placing it in the top 8% for a group of five key ratings, including EPS. 
Via Investor's Business Daily
Australia, New Zealand Express Support To Address USA Baby Food Crisis
Australia is in talks with the U.S. to supply baby food, Reuters reports. 
Via Benzinga
Dexcom Pops After Insulet Buyout Rumor Shakes Up Diabetes Stocks
The deal would have been transformative, but may have limited teamwork in the space. 
Via Investor's Business Daily
$100 Invested In Abbott Laboratories 10 Years Ago Would Be Worth This Much
Abbott Laboratories (NYSE:ABT) has outperformed the market over the past 10 years by 2.65% on an annualized basis producing an average annual return of 14.68%. Currently, Abbott Laboratories has a... 
Via Benzinga
Quant Ratings Updated on 75 Stocks
I decided to revise my Portfolio Grader recommendations for 75 big blue chips -- of those 75, 24 stocks were updated to a buy. 
Via InvestorPlace
< Previous 1 2
...
20 21 22 23 24 25 26 27 28
...
33 34 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.